Evaluate the Safety, Efficacy, and Pharmacokinetics of CRN04894 in Participants With Congenital Adrenal Hyperplasia (TouCAHn)
Clinical trial NCT05907291 · COMPLETED
Trial details
- NCT number
- NCT05907291
- Sponsor
- Crinetics Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-03
- Primary completion
- 2025-08-22
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.